Biddeford-based startup Prapela Inc. is seeking regulatory OK for use of a technology-enabled bassinet pad as a complementary treatment for newborns in opioid withdrawal.

Clearance by U.S. Food and Drug Administration would make Prapela’s product the first such device to treat newborns diagnosed with neonatal opioid withdrawal syndrome, the company said. Read more